Tina Albertson

Keine laufenden Positionen mehr

Vermögen: 13 438 $ am 30.04.2024

51 Jahre

Health Technology

Consumer Services

Ehemalige bekannte Positionen von Tina Albertson

Unternehmen	Position	Beginn	Ende
LYELL IMMUNOPHARMA, INC.	Technik-/Wissenschafts-/F&E-Leiter	01.07.2020	01.11.2023
JUNO THERAPEUTICS INC	Corporate Officer/Principal	01.01.2015	01.04.2020
SEAGEN INC.	Technik-/Wissenschafts-/F&E-Leiter	01.10.2010	01.01.2015

International

Vereinigte Staaten

Operativ

Sektoral

Health Technology	4
Consumer Services	4

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
LYELL IMMUNOPHARMA, INC.	Health Technology

Private Unternehmen	2
Juno Therapeutics, Inc. Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA.	Health Technology
Seagen Inc. Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA.	Health Technology

Private Unternehmen

Health Technology